Literature DB >> 27513347

Cervical cancer: Screening, management, and prevention.

Barbara A Wuerthner1, Maria Avila-Wallace.   

Abstract

Cervical cancer incidence in the United States is estimated to affect 12,900 women in 2016, with 4,100 deaths. Screening for this cancer with Pap test and adjunct human papillomavirus testing has made cervical cancer a treatable disease. This article reviews screening, treatment recommendations, and prevention for cervical cancer.

Entities:  

Mesh：

Year:  2016        PMID： 27513347     DOI： 10.1097/01.NPR.0000490390.43604.5f

Source DB:  PubMed          Journal:  Nurse Pract        ISSN： 0361-1817


  9 in total

1.  Identification of a novel circ_0018289/miR-183-5p/TMED5 regulatory network in cervical cancer development.

Authors:  Heng Zou; Huijia Chen; Shuaibin Liu; Xiaoling Gan
Journal:  World J Surg Oncol       Date:  2021-08-17       Impact factor: 2.754

2.  Efficacy of Bevacizumab Combined with Pemetrexed in the Treatment of Recurrent and Metastatic Cervical Cancer.

Authors:  Ying He; Jing Wang; Shuangshuang Xie; Qianlong Xue
Journal:  Front Surg       Date:  2022-05-16

3.  MicroRNA-30e Functions as a Tumor Suppressor in Cervical Carcinoma Cells through Targeting GALNT7.

Authors:  Huijuan Wu; Jun Chen; Dan Li; Xiangyu Liu; Lei Li; Ke Wang
Journal:  Transl Oncol       Date:  2017-09-27       Impact factor: 4.243

4.  Annexin A1 peptide and endothelial cell-conditioned medium modulate cervical tumorigenesis.

Authors:  Laila Toniol Cardin; Janesly Prates; Bianca Rodrigues da Cunha; Eloiza Helena Tajara; Sonia Maria Oliani; Flávia Cristina Rodrigues-Lisoni
Journal:  FEBS Open Bio       Date:  2019-03-05       Impact factor: 2.693

5.  MicroRNA-377 Targets Zinc Finger E-box-Binding Homeobox 2 to Inhibit Cell Proliferation and Invasion of Cervical Cancer.

Authors:  Cong Ye; Yubo Hu; Junrong Wang
Journal:  Oncol Res       Date:  2018-03-09       Impact factor: 5.574

6.  Efficacy and Safety of Image-Guided Intensity-Modulated Radiation Therapy and Volumetric Modulated Arc Therapy Combined with Paclitaxel Liposomes and Cisplatin for Locally Advanced Stage IIB-IIIB Cervical Cancer: A Retrospective Study at a Single Center.

Authors:  Meihua Xie; Xiuxiu Ding; Aiyu Chen; Huiqin Xiao; Xiaoye Wang; Youhong Wang; Huan Zhang
Journal:  Med Sci Monit       Date:  2020-12-09

7.  The Clinical Significance and Biological Function of PCDH7 in Cervical Cancer.

Authors:  Shitong Zhang; Xianhu Fu
Journal:  Cancer Manag Res       Date:  2021-05-12       Impact factor: 3.989

8.  Clinical Effects of Chinese Herbal Decoction Combined with Basic Chemoradiotherapy and Nursing Intervention in the Treatment of Cervical Cancer and the Effect on Serum CEA, CA125, and TNF-α Levels.

Authors:  Lizhen Gao; Jia Lv; Linlin Hou; Yuchao Yuan; Qiuhua Wan
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-23       Impact factor: 2.629

Review 9.  Cervical cancer therapies: Current challenges and future perspectives.

Authors:  Carly A Burmeister; Saif F Khan; Georgia Schäfer; Nomonde Mbatani; Tracey Adams; Jennifer Moodley; Sharon Prince
Journal:  Tumour Virus Res       Date:  2022-04-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.